相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。What is linking COVID-19 and endothelial dysfunction? Updates on nanomedicine and bioengineering from the 2020 AHA Scientific Sessions
Jessica Gambardella et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
Nunzia D'Onofrio et al.
CARDIOVASCULAR DIABETOLOGY (2021)
SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction
Raffaele Marfella et al.
CRITICAL CARE (2021)
miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells
Pasquale Mone et al.
NON-CODING RNA (2021)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
COVID-19, ACE2, and the cardiovascular consequences
Andrew M. South et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
COVID-19 and Cardiovascular Disease
Kevin J. Clerkin et al.
CIRCULATION (2020)
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
R. Marfella et al.
DIABETES & METABOLISM (2020)
Covid-19: risk factors for severe disease and death
Rachel E. Jordan et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
Celestino Sardu et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Hyperglycaemia on admission to hospital and COVID-19
Celestino Sardu et al.
DIABETOLOGIA (2020)
Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19
Celestino Sardu et al.
CARDIOVASCULAR DIABETOLOGY (2020)
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19
Xiao-Jin Zhang et al.
CELL METABOLISM (2020)
Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy
Celestino Sardu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China
Qing Deng et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
The Enigma of Endothelium in COVID-19
Savneet Kaur et al.
FRONTIERS IN PHYSIOLOGY (2020)
COVID-19 Illness and Heart Failure A Missing Link?
Mandeep R. Mehra et al.
JACC-HEART FAILURE (2020)
COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
Razie Amraei et al.
CELLS (2020)
Endothelial dysfunction in COVID-19: Current findings and therapeutic implications
Matthias P. Nagele et al.
ATHEROSCLEROSIS (2020)
Implications of AB0 blood group in hypertensive patients with covid-19
Celestino Sardu et al.
BMC CARDIOVASCULAR DISORDERS (2020)
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Masataka Nishiga et al.
NATURE REVIEWS CARDIOLOGY (2020)
Statin Use and In-Hospital Mortality in Patients With Diabetes Mellitus and COVID-19
Omar Saeed et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19
Alessandro Matarese et al.
BIOMEDICINES (2020)
Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020
Zijian Feng et al.
CHINA CDC WEEKLY (2020)
Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: Role of epigenetic histone modifications
Kulbhushan Tikoo et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Inflammation and its Resolution as Determinants of Acute Coronary Syndromes
Peter Libby et al.
CIRCULATION RESEARCH (2014)
Anti-inflammatory and anticoagulant effects of pravastatinin patients with type 2 diabetes
DW Sommeijer et al.
DIABETES CARE (2004)